Substituted Pyrazolo-Pyrimidine Compounds for Selective Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments, particularly for metastatic disease, are often palliative and lack long-term curative options, and existing chemotherapies face challenges due to the heterogeneity of cancer cells, making it difficult to predict effective chemotherapeutic agents.
Innovation Solution
Development of substituted pyrazolo-pyrimidine compounds and their use in pharmaceutical compositions to treat cell proliferative disorders and cancer by selectively inducing cell death in precancerous or cancerous cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current chemotherapies are used to treat cancer, then some cancer cells may be killed, but the treatments are mostly palliative and seldom offer long-term cure due to cancer cell heterogeneity
Solution Approach 1:
The patent employs parameter changes by developing a series of substituted pyrazolo-pyrimidine compounds with varying chemical structures (different substituents at positions R1-R4, R6-R10) to target different cancer cell subpopulations. This chemical diversity allows the compounds to address the heterogeneity of cancer cells while maintaining reliable curative effectiveness through selective inhibition of cellular signaling pathways.
2Reliability
If new chemotherapies are developed to address heterogeneous cancer cells, then curative options may improve, but the complexity of predicting effective agents increases
Solution Approach 1:
The patent applies universality by designing pyrazolo-pyrimidine compounds that can function against multiple cancer cell types and signaling pathways simultaneously. The core molecular structure provides a universal platform that can be adapted to target various cellular mechanisms, reducing the complexity of predicting effectiveness across heterogeneous cancer populations while maintaining long-term curative potential.
3Object-affected harmful factors
If substituted pyrazolo-pyrimidine compounds are used to selectively target cancer cells, then cell death in cancer cells is induced, but the selectivity mechanism must be precisely controlled
Solution Approach 1:
The patent implements local quality by introducing specific substituents at defined positions (R1-R4, R6-R10) on the pyrazolo-pyrimidine core structure. Each substituent configuration provides localized chemical properties that enhance selective binding to cancer cell targets while sparing normal cells. This precise local modification allows control over selective targeting precision while effectively inducing cancer cell death.
Data Source
AI summary
The present invention relates to substituted pyrazolo-pyrimidine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted pyrazolo-pyrimidine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds or pharmaceutical compositions to subjects in need thereof.